Skip to main content

Congratulations to our new PhD, Jeffrey DiBerto!

February 3, 2023

Dr. DiBerto successfully defended his thesis, “Discovery Campaigns for Pharmacologically Unique Agonists at the Mu-Opioid and 5-Hydroxytryptamine 2A Receptors on Jan. 19.”